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[3HjRaffinose, a Novel Radioactive Label for Determining Organ Sites 
of Catabolism of Proteins in the Circulation* 
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Jonathan Van Zile, Lee A. Henderson,$ John W. Baynes, and Suzanne R. Thorpe8 
From the Department of Chemistry, College of Science and Mathematics, and School of Medicine, University of South 
Carolina, C&umbia, South Carol&a 29268 
The primary tissue sites of catabolism of plasma 
proteins with long circulating half-lives are unknown. 
It has been difficult to identify these sites because 
plasma proteins are delivered to tissues at relatively 
slow rates but are rapidly degraded intracellularly 
within lysosomes. Therefore, a tracer attached to pro- 
tein is lost from the site of uptake before an amount 
sufficient for quantitation can accumulate. We hypoth- 
esized that sucrose (Glupal-2 /3Fruf) would be a useful 
label to circumvent this difficulty because of the stabil- 
ity of sucrose in lysosomes; and thus, sucrose should 
remain in tissue long after the protein to which it was 
attached had been degraded to products released from 
the lysosome. [G-3HJRaffinose (RAF, Galpal- Glupcwl- 
2flFruf) was selected as the vehicle for attaching su- 
crose to protein. [31XjRAF was converted to the C-6 
aldehydogalactose form with galactose oxidase and 
then covalently coupled to protein by reductive ami- 
nation using NaBH3CN. 
[‘H]RAF was coupled first to two relatively long lived 
plasma proteins, bovine serum albumin and fetuin. The 
half-lives of these proteins in the rat circulation (&,* = 
-24 h) was unchanged, suggesting that RAF did not 
alter the normal mechanisms of protein clearance. 
When attached to short lived proteins with known sites 
of catabolism, such as asialofetuin, RNase B, and heat- 
denatured albumin, neither the tissue nor cellular sites 
of uptake of the proteins were altered. Thus, 13H]RAF- 
asialofetuin was recovered almost exclusively (>90%) 
in the liver parenchymal cell fraction, while both 
[JHJRAF-labeled RNase B and heat-denatured albumin 
were recovered primarily (>85%) in nonparenchymal 
cells. In addition, the RAF label was observed to reside 
stably (tl,2 > 100 h) in the liver following degradation of 
the carrier protein; in contrast, radioactivity from “‘I- 
labeled asialofetuin or RNase B was rapidly (tl,z < 30 
min) lost from liver. Radioactivity from 13H]RAF-pro- 
teins was recovered in a lysosomally enriched subcel- 
lular fraction in liver and consisted of a low molecular 
weight species (-llOO), containing both glucose and 
fructose in a ratio similar to that in the original pro- 
tein. The results of these studies establish that 13H]RAF 
* This work was supported by United States Public Health Service 
Research Grant AM19971 and National Institutes of Health Biomed- 
ical Research Support Grant 5S07RR07160. A preliminary report of 
this work has appeared (1). The costs of publication of this article 
were defrayed in part by the payment of page charges. This article 
must therefore be hereby marked “aduertisement” in accordance 
with 18 USC. Section 1734 solely to indicate this fact. 
* This work has been submitted, in part, in partial fulfillment of 
the requirements for a Master of Science degree in Chemistry from 
the University of South Carolina. 
5 To whom all correspondence should be addressed at the Depart- 
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29208. 
covalently coupled to plasma proteins should be a use- 
ful radioactive tracer for detecting the tissue and cel- 
lular sites of catabolism of long lived circulating pro- 
teins. 
There is extensive information concerning the sites of syn- 
thesis and kinetics of turnover of plasma proteins; however, 
there is little firm evidence concerning their mechanisms of 
clearance from the circulation or their tissue sites of degra- 
dation (2-4). Perhaps the greatest technical difficulty in ob- 
taining this information has been the absence of a suitable 
radioactive label with which to monitor the sites of catabolism 
of proteins with the long circulating half-lives characteristic 
of plasma proteins. In general, the rate of intracellular degra- 
dation of plasma proteins within lysosomes far exceeds the 
rate of clearance of these long lived proteins. Thus, if plasma 
proteins are labeled with conventional labels, such as ? or 
radioactive amino acids, the tracer does not accumulate at the 
site of catabolism, but, rather, as the protein is degraded to 
monomeric products which exit from the lysosome, the label 
is lost to cellular or extracellular metabolic pools, or both. In 
contrast, the sites of catabolism of proteins with short circu- 
lating half-lives are readily identified since their rates of 
clearance are relatively rapid, compared to the rate of lyso- 
somal digestion. It has been possible, therefore, to identify the 
liver as the primary site for catabolism of [“H,%u]asialocer- 
uloplasmin (5) and lz51-RNase B (6) injected in rats, and 
bovine /3-glucuronidase injected in mice (7), all proteins which 
exhibit half-lives of 15 min or less. 
In order to circumvent the difficulties inherent in determin- 
ing the in. uiuo fate of long lived plasma proteins, a tracer is 
needed which will 1) not affect mechanisms of protein clear- 
ance and catabolism, 2) be resistant to degradation by lyso- 
somal hydrolases, and 3) accumulate in lysosomes at the site 
of the labeled protein’s degradation. We hypothesized that 
sucrose (Glcpcyl-ZPFru,) covalently attached to protein 
through its glucosyl moiety might fulfill these criteria for the 
following reasons. First, because of the stable equilibration of 
inulin (a fructan) and rafiinose (RAF, Galpcul-GGlcpal- 
2/3Frun into plasma and extravascular spaces in uivo (8), it 
seemed unlikely that the terminal fructose residues on a 
protein would serve as recognition markers for a carbohy- 
drate-dependent clearance process analogous to those already 
described for galactose (9), fucose (lo), mannose (11, 12), and 
N-acetylglucosamine (13,14) terminal glycoproteins. Second, 
because of the absence of significant levels of mammalian 
lysosomal sucrase activity (15), it seemed unlikely that hy- 
drolysis of the sucrose moiety would occur either before or 
after degradation of the protein. Finally, since sucrose does 
not readily diffuse from lysosomes (15), it or its amino acid 
conjugate should accumulate at this subcellular site of protein 
3547 
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3548 Determination of Sites of Catabolism of Circulating Proteins 
catabolism, despite the fact that other components of the 
protein would exit from the lysosome following degradation. 
As a vehicle for the attachment of sucrose to protein, we 
chose the trisaccharide [G-3H]raffinose as our radioactive 
starting material. Oxidation of the C-6 hydroxyl of the galac- 
tose residue, using galactose oxidase (16), provided an alde- 
hyde function which could be readily coupled to protein, 
under mild conditions, using NaBH3CN (17). We present 
below the results obtained in vitro for the coupling of RAF’ 
to several proteins by this method. We also present our results 
from studies on the comparative fates of 12?- and [“HIRAF- 
labeled proteins in viuo, as a test of our hypothesis that RAF 
attached to protein would be a stable, inert, label useful for 
determining the organ and cellular sites of plasma protein 
catabolism. 
EXPERIMENTAL PROCEDURES 
Materials-The following materials were purchased from the in- 
dicated sources: [G-JH]RAF (-1500 mci/mmol) and Na’? (New 
England Nuclear); ‘*?-human serum albumin, (Mallinckrodt Labo- 
ratories); RAF, Glu, Gal, and Fru (P & L Laboratories); galactose 
oxidase, catalase, insolubihzed neuraminidase, and NaBH&N 
(Sigma). Bovine serum albumin (Pentex Laboratories) was heat-de- 
natured according to the method of Cohen and Gordon (IS). RNase 
B (Sigma type XII-B) was assayed, purified, and iodinated as previ- 
ously described (6, 11). Asialofetuin was prepared from fetuin (Grand 
Island Biologic Co.) using insolubilized neuraminidase at 25°C for 18 
h in 0.1 N sodium acetate, pH 5.2; sialic acid release was 75% of 
theoretical as judged by the thiobarbituric acid assay (19). ‘““I-labeled 
albumin, fetuin, and asialofetuin were prepared using the lactoper- 
oxidase technique (20) and reisolated by chromatography on Bio-Gel 
P-150 (Bio-Rad Co.). 
Coupling of RAF to Protein-A typical reaction mixture for the 
conversion of RAF to raffinaldehyde contained 1 pmol of RAF, 20 
units of galactose oxidase (150 pg of protein), and 130 units of catalase 
(10 pg of protein) in 1 ml of 0.1 N potassium phosphate buffer, pH 7.5, 
and was incubated for 4 h at 37°C. Using the Nelson-Somogyi 
procedure (21) to monitor aldehyde production, 75 to 80% of the 
theoretical amount of aldehyde was generated under these conditions 
(16). Longer times of incubation, further additions of enzyme, or 
increasing the initial amount of enzyme did not alter the yield of 
aldehyde. Aldehyde generated in this manner was stable to freezing 
for at least 10 days. In the coupling procedure, protein in 0.1 N 
potassium phosphate, pH 7.5, was mixed with 1 to 3 molar equivalents 
of aldehyde, and then NaBH&N was added in the same buffer to a 
final concentration of 1 mg/ml (17 mM); coupling was carried out for 
18 to 24 h at room temperature in a sealed tube. The kinetics or 
extent of coupling were determined in aliquots removed at desired 
times by measuring radioactivity or anthrone-positive (21) material, 
precipitable by acid, or both. Albumin was precipitated by the addi- 
tion of an equal volume of 10% trichloroacetic acid; fetuin and RNase 
B were precipitated with 5% phosphotungstic acid in 2 N HCl, and 
2.5% uranyl acetate in 12.5% trichloroacetic acid, respectively. Radio- 
labeled protein was isolated from incubation mixtures by chromatog- 
raphy on Bio-Gel P-150 (albumin, fetuin) or Sephadex G-75 (Phar- 
macia, RNase B) columns in 0.1 N ammonium acetate. Column 
effluents were monitored for absorbance at 280 nm or radioactivity, 
or both, and appropriate fractions were pooled, lyophilized, and 
redissolved in 0.9% NaCl for injection experiments. 
In Viva Experiments-Experiments were conducted in male 
Sprague-Dawley rats (175 to 225 g) under ether anesthesia. Experi- 
ments with RNase B were carried out in nephrectomized animals as 
previously described (6). For half-life determinations, proteins were 
injected intracardially and blood samples were removed at timed 
intervals from lateral tail veins. After centrifugation, radioactivity 
was determined in measured plasma aliquots. Organs were thoroughly 
perfused with saline (0.9% NaCl solution) before sampling for radio- 
activity determinations (6). For measurement of ‘H radioactivity, 
weighed aliquots of tissue were homogenized in 4 volumes of H&, 
and O.l- to 0.2-ml aliquota were solubilized overnight at 25°C in 0.25 
ml of 20% sodium dodecyl sulfate; when decolorization was needed, 
10 to 20 ~1 of 30% Hz02 were added and samples were heated at 50°C. 
3H radioactivity was counted in a Triton X-100 toluene-based scintil- 
..--__- __- 
’ The abbreviation used is: RAF, raffinose. 
lation fluid (Beckman Bio-Solv EP). Weighed portions (-1 g) of tissue 
from ““I-protein injection experiments were counted directly in a 
Beckman Gamma 4000 gamma counter. Isolation of parenchymal and 
non-parenchymal cells of liver by collagenase digestion and differen- 
tial centrifugation was carried out as previously described (6). Sub- 
cellular fractionation of liver by differential centrifugation into nu- 
clear, mitochondrial/lysosomal, and supernatant fractions was per- 
formed according to Gregoriadis and Sourkes (22) using P-N-acetyl- 
hexosaminidase activity (23) as a lysosomal marker enzyme. 
In order to characterize products resulting from the in uiuo degra- 
dation of [gH]RAF-labeled proteins, livers were taken at various times 
postinjection of heat-denatured albumin or asialofetuin; the livers 
were homogenized in 4 volumes of H20, frozen, and thawed four to 
five times and then centrifuged at 12,000 x g for 30 min. The 
supernatant, containing 90 to 100% of the original radioactivity, was 
then passed through an Amicon PM-10 filter (nominal molecular 
weight cut off, lO,OOO), and 95 to 100% of the supernatant radioactivity 
was recovered. The ultrafiitrate was then lyophilized, redissolved in 
a small volume of 0.1 M ammonium acetate, and chromatographed on 
a Bio-Gel P2 column. Radioactive peaks were pooled and lyophilized, 
and their content of radioactive sugars was determined following 
hydrolysis in 2.0 N trifluoroacetic acid at 110°C for 3 h. Component 
sugars were separated by paper chromatography in a butanol/pyri- 
dine/water (9:5:4) solvent system and visualized using a sodium 
periodate/silver nitrate staining procedure (24). Radioactivity was 
located and quantitated by counting 5-mm sections of the paper 
chromatogram directly in scintillation fluid containing 10% H20. 
RESULTS 
In Vitro Experiments: Protein Modification 
The overall scheme for the production of raffinaldehyde 
and its coupling to protein is shown in Fig. 1. As indicated, 
attachment of carbohydrate to protein by reductive amination 
required the presence of an aldehyde function on the sugar. 
This aldehyde function was introduced at the C-6 position of 
the galactose moiety of RAF using galactose oxidase. Catalase 
was included in the incubation mixture in order to destroy 
H202 produced during the oxidation reaction (16). Because of 
the selectivity of NaBH3CN for reduction of Schiff bases 
above pH 5 (25), the coupling reaction theoretically could be 
carried out simultaneously with the generation of aldehyde. 
However, since preliminary experiments indicated that 
NaBH3CN was inhibitory to galactose oxidase, the two reac- 
tions were carried out sequentially. A pH of 7.5 was chosen as 
the pH for coupling in order to keep plasma proteins close to 
physiologic pH and yet have conditions alkaline enough to 
Na BH,CN 
FIG. 1. General reaction sequence for the enzymatic production of 
raffinaldehyde and ita chemical attachment to protein. 
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Determination of Sites of Catabolism of Circulating Proteins 3549 
allow coupling to proceed at a reasonable rate (17, 26). The 
gel chromatographic profiles of modified proteins were iden- 
tical to those of the starting preparations; RNase B enzymatic 
activity was unaffected by attachment of approximately 0.1 
mol of RAF/mol of protein. 
The kinetics of attachment of RAF to albumin under the 
conditions chosen as standard are illustrated in Fig. 2. The 
reaction was found to proceed at a relatively rapid rate for 
approximately 4 h and then continued more slowly thereafter. 
It should be noted that the amount of protein-bound carbo- 
hydrate (acid-precipitable) was consistently found to be some- 
what greater when determined by the anthrone method (21) 
than by radioactivity measurements. The reported specific 
activity of the commercial [“H]RAF was determined and 
found to be correct, and its purity was confirmed by paper 
chromatography. There was also no evidence of hydrolysis of 
[3H]RAF to its component sugars during the incubation with 
galactose oxidase or during the coupling reaction. The dis- 
crepancy between anthrone and radioactivity measurements 
may be explained by a kinetic isotope effect resulting from 
tritiation at the C-6 position of galactose and preferential 
oxidation of the unlabeled RAF by galactose oxidase. Neither 
increasing the time cf exposure of [“HIRAF to galactose 
oxidase, nor increasing the amount of enzyme in the standard 
incubations affected the extent of coupling of radioactivity to 
protein. Since radioactivity was the only parameter which 
could be conveniently assessed in either in uiuo experiments 
or when RAF was coupled to glycoproteins, the amount of 
RAF coupled was normally based on the specific activity of 
the [3H]RAF used. Under the standard conditions described 
in Fig. 2, 30 to 38 nmol of RAF were routinely coupled/100 
nmol of albumin. 
Table I describes the effect of varying selected reaction 
parameters on the amount of RAF bound to protein. The 
amount of RAF attached to albumin did not increase when 
the NaBH3CN concentration was greater than 1 mg/ml (Ex- 
periment 2) but was decreased at lower concentrations (Ex- 
periments 3 and 4). In control experiments RAF was not 
coupled to protein unless NaBH3CN was included in incuba- 
tion mixtures. The extent of coupling was not affected when 
the reaction was incubated at 37°C (Experiment 5) but was 
decreased approximately 65% at 4°C (Experiment 6). The 
proportion of RAF coupled to albumin did not increase in a 
linear fashion when the proportion of aldehyde in the reaction 
mixture was increased (Experiments 7 and 8), suggesting a 
limited number of kinetically accessible amino groups under 
the conditions used. Finally, under standard conditions a 
characteristic amount of RAF was bound to each of the 
TIME (HOURS) 
FIG. 2. Kinetics of coupling of raffinaldehyde to albumin. Equi- 
molar (0.1 mru) amount of raffbmldehyde and albumin were incubated 
at pH 7.5 in the presence of 1 mg/ml of NaBH&N; at indicated times 
aliquots were removed and anthrone-positive or radioactive material 
precipitable by acid, or both, were quantitated as described under 
“Experimental Procedures.” 
TABLE I 
Effect of varying reaction conditions on the coupling of raffinose to 
protein 
Conditions” 
EX- 
peri- Tem- Raftin- 
merit pen- [NaBH&N] ;.$; 
ture protein’ 
[Protein] 
Resuld 
“C rnM 
1” 25 17 1:l 0.1 miu albumin 
2 25 34 1:l 0.1 mM albumin 
3 25 8.5 1:l 0.1 mru albumin 
4 25 1.7 1:l 0.1 mM albumin 
5 37 17 1:l 0.1 mM albumin 36 
6 4 17 1:l 0.1 mru albumin 17 
7 25 17 lo:1 0.01 mM albumin 
8 25 17 3O:l 0.01 mM albumin 
9 25 17 I:1 0.2 mM f&Uin 
10 25 17 1:l 0.2 mM asialofetuin 
11 25 17 1:l 0.2 mrvr RNase B 
mol raffi- 
nose/h 
mol pro- 
tein 
33 
33 
20.5 
10.9 
100 
210 
20 
1 
10 
“All coupling reactions carried out in 1 ml of 0.1 N potassium 
phosphate buffer, pH 7.5, for 24 h with other parameters varied as 
indicated, 17 mM NaBH:,CN = 1 mg/ml. 
’ Amount of raffinose coupled based on acid-precipitable radioac- 
tivity. 
’ Raftinaldehyde generated from 1 mM raffinose at pH 7.5, 37°C. 
using galactose oxidase and measured by the Nelson procedure as 
described under “Experimental Procedures.” 
’ Conditions of this reaction defined as standard. 
proteins tested (Experiments 9 to 11). As seen in Table I, 
asialofetuin was a much poorer substrate for the coupling 
reaction than fetuin, itself; therefore, [3H]RAF-asialofetuin 
was prepared by enzymatic desialylation of [“HIRAF-fetuin. 
The differential reactivity of fetuin and asialofetuin in the 
coupling reaction may result from a conformational change in 
fetuin’s structure upon removal of charged sialic acid residues. 
Alterations in other reaction parameters, particularly pH and 
time of incubation (26), can be expected to enhance the extent 
of RAF attached to proteins; in order to minimize structural 
alterations in proteins to be studied in uiuo particularly gentle 
conditions for coupling were chosen in these experiments. 
In Viuo Experiments 
Half-life Studies-Alterations in protein structure are often 
reflected by changes in their circulating half-life in uiuo (2). 
Therefore, by comparing the half-lives of l*‘I- and [3H]RAF- 
labeled proteins in uiuo, the effect of RAF attachment on this 
biological property of proteins can be evaluated. The results 
of studies comparing the kinetics of clearance of several lz51- 
and [3H]RAF-labeled proteins are shown in Fig. 3. Panel A 
demonstrates that, whether labeled with “‘1 or [“HIRAF, both 
asialofetuin and RNase B were rapidly cleared from the 
circulation. The rapid kinetics of clearance were expected 
since these proteins are recognized by separate carbohydrate- 
dependent clearance systems specific for glycoproteins with 
terminal galactose (asialofetuin (9)) and mannose (RNase B 
(11)) residues. The data of Panel A indicated that the attach- 
ment of RAF did not prolong the circulating half-life of 
asialofetuin and RNase B by interfering with these specific 
recognition systems. 
In Fig. 3B, the circulating half-lives of ‘*‘I- and [“H]RAF 
derivatives of fetuin, a long lived protein, are compared. In 
this experiment fetuin was iodinated under mild conditions 
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Determination of Sites of Catabolism of Circulating Proteins 
ASIALOFETUIN 
20 
& 
100 
o 12’1- ALBUMIN o’251- FETUIN 
h n [3H] - RAFFINOSE 
0 I  
\  
- t g22.4 hr 
FETUIN I- ALBUMIN 
P . ‘251, RAFFINOSE- 1 
IO 50 100 8 40 72 104 8 40 72 104 
TIME (MINUTES) TIME (HOURS) TIME (HOURS) 
FIG. 3. Kinetics of clearance of various “‘1. and [“HIRAF-labeled 
proteins from the rat circulation. Animals were injected with radio- 
labeled compound and blood samples were taken at indicated times; 
radioactivity was determined in measured plasma aliquots. Data is 
based on at least two animals/experiment and points represent av- 
erage values, which typically varied by 5 percentage points. Panel A, 
A-A, 2 x 10”; cpm (0.1 mg) of ‘*“I-asialofetuin; A-A, 2.8 X 10” 
using the lactoperoxidase technique (20) and then reisolated 
by gel chromatography so that minimal denaturation was 
expected. The chromatographic profile and half-life of [3H]- 
RAF-fetuin were essentially identical to that of ‘““I-fetuin, 
suggesting that the coupling of RAF did not cause significant 
changes in the physical or biological properties of the protein. 
Aa anticipated, the half-life of C3H]RAF-fetuin, -24 h, was in 
marked contrast to the 3- to 5-min half-life observed for the 
asialo derivative (9). Determination of the acid precipitability 
of ‘H radioactivity recovered from plasma over a 72-h period 
yielded 93 to 99% precipitability. 
In experiments with bovine serum albumin (Fig. 3C), one 
preparation was labeled with lz51, while another was first 
coupled with unlabeled RAF, in a molar ratio of 51 (RAF: 
albumin, determined by anthrone), and then iodinated by the 
lactoperoxidase technique (20). The circulating half-life of 
each preparation was -24 h. In data not shown, the half-life 
of a commercial preparation of L251-human serum albumin was 
17 h. These data suggest that modification of albumin with up 
to 5 molecules of RAF did not cause either an increased or 
decreased rate of uptake of albumin from the circulation. 
Tissue Studies--In order to verify the stability of r’H]RAF 
in tissue following protein uptake, the hepatic recovery of 
asialofetuin, heat-denatured albumin, and RNase B, labeled 
with either “‘1 or [3H]RAF, was compared. Table II illustrates 
that at early times postinjection the extent of recovery of 
radioactivity from proteins labeled by either method was 
comparable. However, for iodinated proteins, free iodide is 
rapidly released from the liver upon degradation of the pro- 
tein (27). This loss is apparent even as early as 30 min, and by 
24 h only traces of “‘1 were recovered in liver from either lz51- 
labeled asialofetuin or RNase B. In marked contrast, however, 
at 24 to 96 h, significant (90 to 60%) amounts of “H from 
[“H]RAF/asiaIofetuin were still present in liver. Over a 96-h 
time period, “H radioactivity declined from 90% of dose at 
30 mm to 60% of dose at 96 h, giving an approximate half-life 
of 109 h. The recovery of radioactivity from liver at 24 and 48 
cpm (0.4 mg) of [3H]RAF-asialofetuin; 0--O, 10 X 10” cpm (0.05 
mg) of ‘*‘I-RNase B; M, 5 x 10” cpm (0.3 mg) of [‘H]RAF- 
RNase B. Panel B, D----o, 7 X 10” (0.1 mg) of lp51-fetuin; H, 
5 x lo5 cpm (0.5 mg) of r’H]RAF-fetuin. Panel C, W, 17 X 10” 
cpm (0.3 mg) of ‘251-albumin; W, 17 x 10” cpm (0.3 mg) of “‘1 
(5 mol of raffinose/mol)-albumin. 
TABLE II 
Hepatic recovery of radioactivity from “‘Z- and f3HJraffinose- 
labeled proteins 
% injected dose” Heat-dena- 
Time postin- 
jection Asialofetuinn RN&se Bh 
tured albu- 
min 
h 
0.15 
0.5 
24.0 
48.0 
72.0 
96.0 
90 
58 90 20 22.5 38 
<I 86 Cl 26.5 32 
74 19.0 
60 36 
-Cl 60 
” Livers were removed at indicated times postinjection and homog- 
enized, and radioactivity was determined in aliquots of homogenate 
as described under “Experimental Procedures.” Results are the av- 
erage value from at least two rats/time point which typically differed 
by less than 5 percentage points. 
’ Animals were injected with 2 to 5 x lo6 cpm of ““I- or [“HIRAF- 
labeled proteins. 
h postinjection, 90 and 74%, was matched by a concomitant 
appearance of 14 and 26% of dose, respectively, in urine at 
these two times. Radioactivity in lung, kidneys, spleen, and 
heart at these same time points accounted in toto for less than 
1% of dose. These data demonstrate that the radioactivity lost 
from liver following uptake of cH]RAF-asialofetuin was not 
reutilized by other tissues but was excreted in the urine. In 
contrast to the gradual decline of recovered radioactivity 
following asialofetuin injections, radioactivity from [“HIRAF- 
heat-denatured albumin or RNase B appeared to be more 
stable over a 48- to 72-h period. RNase B experiments were 
limited to 48 h because the animals had been nephrectomized. 
Since asialofetuin is known to be cleared in hepatocytes (9), 
whereas RNase B and heat-denatured albumin are cleared in 
hepatic non-parenchymal cells (2, 6), differences observed in 
the stability of the RAF label from asialofetuin or heat-de- 
natured albumin and RNase B injections may reflect differ- 
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Determination of Sites of Catabolism of Circulating Proteins 3551 
ences in the rate of turnover of cells or lysosomal contents in 
one cell type from another. In these experiments radioactivity 
not recovered in liver could be accounted for in blood and 
tissues of the reticuloendothelial system (see “Discussion”). 
The total body and hepatic distribution of radioactivity fol- 
lowing inject,ion of [“H]RAF-RNase B was essentially identical 
to that previously reported for ““I-RNase B (6). 
Cell Separations-As a test of whether the RAF label 
would affect the known cellular sites of clearance of asialofe- 
tuin and heat-denatured albumin by parenchymal and non- 
parenchymal cells, respectively, the cell type in which radio- 
activity was localized after injection of each of these proteins 
was determined. Table III demonstrates that, based on the 
ratio of the specific activity (counts per min/cell) of the final 
purified parenchymal and non-parenchymal cell fractions, and 
an average ratio of two parenchymal cells/non-parenchymal 
cell in the initial cell suspension of liver (2&S), greater than 90% 
of the radioactivity from [“HIRAF-asialofetuin injections was 
accounted for in hepatocytes. By a similar calculation, 85 to 
90% of the hepatic radioactivity from heat-denatured albumin 
experiments was initially present in non-parenchymal cells. In 
experiments to be reported in detail elsewhere, [“HIRAF- 
RNase B was also recovered primarily (>85%) in non-paren- 
chymal cells at 0.5 to 24 h postinjection. There is some 
variation in relative specific activities of the two cell types 
among experiments, but this probably results from day to day 
variations in the cell isolation technique. The preferential 
localization of asialofetuin, heat-denatured albumin, and 
RNase B in the expected cell type supports the hypothesis 
that the attachment of RAF does not affect specific cellular 
uptake of proteins by pinocytic (asialofetuin, RNase B) or 
phagocytic (heat-denatured albumin) processes. 
Subcellular Localization-The expected lysosomal locali- 
zation of recovered radioactivity from [3H]RAF-labeled pro- 
teins is illustrated in Table IV. The data also indicated that in 
addition to being stable in the liver for extended periods, the 
radioactivity from [“HIRAF protein injections remained in 
the lysosomally enriched subcellular fraction over a 48- to 72- 
h period. The recovery of the lysosomal marker enzyme P-N- 
acetylhexosaminidase exactly paralleled that found for the 
radioactivity. 
Characterization of Degradation Products-Fig. 4 shows 
TABLE III 
Hepatic cell type of recovery of radioactivity from [3H]raffinose- 
labeled proteins 
Time post- 
injection 
[“H]RAF-asialofetuin” [‘HIRAF-heat-dena- tured albumin” - 
sp. act, pc” Calculated 
R cpm in 
sp. act. NPC” Calculated 
sp. act. NPC pc’ sp. act. PC % cpm in NPC’ 
h 
0.5 
24.0 
48.0 
72.0 
9.2 95 31 94 
12.2 86 
6.7 93 
12.1 96 11 85 
” Animals were injected with 2 x 10” cnm of T”HlRAF-asialofetuin _ _~ 
or 4 x Id cpm of [“Hlraffinose-heat-denatured albumin. 
* The ratio of specific activity (sp. act.) is based on the counts per 
min/cell of the purified parenchymal (PC) and nonparenchymal 
(NPC) cells obtained from livers at indicated times after collagenase 
perfusion and differential centrifugation as described under “Experi- 
mental Procedures.” Average purities of each cell type were 96 to 99% 
and average recoveries of parenchymal and non-parenchymal cells 
were 70 and 30% of cells in the initial cell suspension of liver, 
respectively. 
’ Calculated per cent of radioactivity in parenchymal or non-paren- 
chymal cells in whole liver based on ratio of specific activities and 
observed average ratio of parenchymal/nonparenchymal cells of 2. 
TABLE IV 
Hepatic subcellular distribution of radioactivity recovered from 
[3HJraffinose proteins 
‘5 recovered radioactivity” in subcellular fraction 
Time [“H]RAF-asialofetuinh ]‘H]RAF-denatured albumin” 
postinjec- 
tion Mito- Nuclear chondrial Superna- Mitchon- 
lylzlo- 
tant Nuclear drial ly- S”~~~~- sosomal 
h 
0.5 13 83 4 20 70 10 
24.0 17 74 9 
72.0 13 76 11 
” Recoveries of radioactivity in fractions were 85 to 100% of that 
found in the whole homogenate. 
h Animals injected with 2.5 x 10” cpm of [‘HIRAF-asialofetuin and 
4 x IO” [“HIRAF-heat-denatured albumin; livers were removed at 
indicated times and weighed portions homogenized in 0.25 M sucrose 
followed by differential centrifugation to obtain subcellular fractions 
described under “Experimental Procedures.” 
0. I 
30 40 50 60 70 
\ 
U NKNOWN-+O 
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\ 
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\ 
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\ 
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I,,&, , , , , , , , 
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FIG. 4. Bio-Gel P-2 chromatography of soluble radioactivity re- 
covered after administration of [3H]RAF-proteins. Panel A, animals 
were injected with [:‘H]RAF-asialofetuin ([“HIRAF-ASF, X-X) or 
[“HIRAF-heat-denatured albumin ([“H]RAF-HDA, M) and 
killed after 24 h, and soluble radioactivity was recovered after freeze- 
thaw of liver as described under “Experimental Procedures.” Column 
dimensions, 110 X 1.5 cm; fraction size, 2.5 ml. Panel B, calibration of 
P-2 column with carbohydrate standards: stachyose (666), raffinose 
(504), melibiose (342), galactose (180) detected with anthrone. 
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3552 Determination of Sites of Catabolism of Circulating Proteins 
the gel chromatographic profile of the soluble radioactivity 
recovered after freeze-thaw of livers obtained 24 h after ad- 
ministration of either [3H]RAF-labeled asialofetuin or heat- 
denatured albumin. Essentially identical profiles were also 
found for degradation products obtained from livers at 72 and 
96 h postinjection of [“H]RAF-labeled heat-denatured albu- 
min and asialofetuin, respectively. Based on the calibration 
curve shown in Fig. 4B, the molecular weight of the unknown 
peak was approximately 1100. Since essentially 100% of dose 
from asialofetuin injections was accounted for by the sum of 
recovered radioactivity in liver and urine, it seems likely that 
the entire RAF molecule is recovered attached to a small 
peptide derived from the protein. Paper chromatography of 
hydrolysates of the degradation products recovered from the 
P-2 column indicated that both radioactive fructose and glu- 
cose are recovered in a ratio essentially identical to that found 
for the starting protein. 
DISCUSSION 
A major gap in our knowledge of the metabolism of plasma 
proteins is the lack of essential information on the regulation 
of homeostatic concentrations of these proteins in plasma. To 
understand how plasma protein metabolism is regulated, it is 
at least necessary to identify the sites of catabolism of these 
proteins. The experiments described in this report represent 
an effort to overcome a major obstacle in the accurate deter- 
mination of these sites of catabolism, namely that, although 
these proteins are delivered to tissues at a relatively slow rate 
(e.g. tlrz r 24 h), rates of degradation in tissues (e.g. tlr2 5 15 
min) are relatively rapid. Thus, any radioactive tracer at- 
tached to protein is lost from the site of uptake at a rate too 
great to allow quantitation. 
We sought to develop an inert, indigestible radioactive tag 
which would accumulate at the tissue site of a protein’s 
degradation and, thus, measure the cumulative degradation 
of the protein in that tissue. Sucrose seemed especially attrac- 
tive as a radioactive ligand for this purpose because of its 
demonstrated stability in lysosomes. Recently, based on a 
similar rationale, Pittman and Steinberg (29) reported the 
attachment of [14C]sucrose to low density lipoprotein and 
albumin, via a succinate spacer arm. Their in vitro studies of 
the uptake of the labeled proteins by cells in culture demon- 
strated both accumulation and stability of the radioactive 
label in cells over a 6-h period. While these initial observations 
are promising, there are limitations inherent in this method 
for attaching sucrose to protein. The attachment through the 
succinate spacer alters the charge of protein both by conver- 
sion of an amine to an amide function and by addition of 
negative charge from uncoupled succinate groups on the su- 
crose moiety. In addition, the ester linkage between sucrose 
and the linking succinate arm may well be susceptible to 
plasma esterases in viva In contrast, use of reductive amina- 
tion to couple RAF, and thus sucrose, to protein results in 
minimal alterations in charge and isoelectric point of the 
modified protein. Further, we have observed that the label is 
completely stable under in viuo conditions. As noted above, 
the coupling procedure can be performed under mild, physi- 
ological conditions and does not result in any modification of 
gel chromatographic behavior of the proteins studied or the 
enzymatic activity of RNase B. The studies presented also 
document that the kinetics and sites of clearance of RAF- 
labeled proteins are essentially identical to those found for 
‘?-labeled proteins, suggesting that, in fact, there is no major 
alteration in the physical and biological properties of the 
modified proteins. 
A basic assumption in the choice of sucrose as in indigestible 
tracer is the absence of sucrase or ,&fructofuranosidase activ- 
ities in mammalian lysosomes. There has been, however, a 
report of a low but detectable level of sucrase in rat liver 
lysosomes (30). As shown above, while the RAF label is 
particularly stable in non-parenchymal cells, there was a 
measurable loss of the RAF radioactivity with time from 
hepatocytes. This could result from normal hepatocyte turn- 
over but is unlikely to result from enzymatic degradation of 
the RAF-amino acid conjugate. As noted above, 100% of 
injected dose of [“H]RAF-asialofetuin could be accounted for 
in liver and urine at all times. In addition, only a single low 
molecular weight species was detected on Bio-Gel P-2 from 
either of these sources, for as long as 96 h postinjection, and 
contained both glucose and fructose in the expected ratios. 
These data suggest that either RAF attached to protein is not 
a suitable substrate for the sucrase described by Horvat (30) 
or that the sucrase activity is too low to be detectable during 
the course of our experiments. It should also be noted that, 
since the loss of radioactivity from hepatocytes is not detect- 
able for at least 24 h postinjection and has an approximate 
half-life of 100 h, experiments to study the sites of uptake of 
proteins with long circulating half-lives can be carried out 
over at least a 48-h period, with little loss of accumulating 
radioactivity in parenchymal cells, should this prove to be a 
site of uptake. 
The emphasis of the experiments reported here has been to 
study the stability of the [3H]RAF label in liver, as a model 
for its stability in other tissues. The data obtained to date 
verify this stability in liver and in the lysosomal subcellular 
fraction of both hepatic cell types. In preliminary studies, 
radioactivity not found in liver from [3H]RAF-heat-denatured 
albumin injections could be accounted for primarily in kidney, 
spleen, and lung, other organs of the reticuloendothelial sys- 
tem expected to participate in the clearance of aggregated 
protein (2). The recovery of radioactivity in these organs 
appears to have a stability comparable to that found for liver, 
and only 6.5% of dose was found in urine over a 72-h period. 
The uptake of RNase B also occurs in organs of the reticulo- 
endothelial system, but a large proportion is found in muscle 
and hide (6). Thus, this protein should also be useful for 
evaluating the stability of RAF in nonhepatic tissue. 
Since the ultimate goal of our research is to investigate 
regulation of plasma protein catabolism, it was essential to 
document that the RAF label did not interfere with normal 
mechanisms of clearance or elicit clearance by different path- 
ways. The recovery of asialofetuin in hepatocytes and RNase 
B and heat-denatured albumin in non-parenchymal cells of 
liver suggests that the normal mechanisms of clearance were 
operating on RAF-labeled proteins. The fact that ?- and 
RAF-labeled fetuin and albumin were cleared from the cir- 
culation with similar kinetics also suggests that attachment of 
RAF did not interfere with the normal uptake mechanisms 
for these proteins. 
One other important aspect of the use of RAF as a label is 
that it should accumulate with time in the tissues active in 
catabolism of long lived proteins, as protein is slowly delivered 
to those tissues. In one set of preliminary experiments study- 
ing the hepatic recovery of [3H]RAF-fetuin (circulating half- 
life, -24 h), the recovery of radioactivity at 12, 24, and 48 h 
postinjection was 21, 29, and 36% of dose, respectively. At 
these same times there was a concomitant decrease in radio- 
activity in plasma from 41 to 23 to 12% of dose (Fig. 3). These 
encouraging initial findings with [3H]RAF-fetuin are entirely 
consistent with the hypothesis that the recovery of the RAF 
label from a protein with a long plasma half-life would show 
a progressive increase in a tissue involved in the catabolism of 
that protein, as it is slowly removed from the circulation. An 
additional 7 and 14% of dose from C3H]RAF-fetuin was re- 
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Determination of Sites of Catabolism of Circulating Proteins 3553 
covered in urine at 24 and 48 h postinjection. Thus, blood, 
liver, and urine accounted for about 60% of dose at the three 
times studied. The remainder of radioactivity could be ac- 
counted for in other visceral organs and extravascular com- 
partments. Details of these experiments will be presented 
elsewhere. 
In summary, from the experiments presented above, we 
conclude that [3H]RAF functions as a biologically inert, indi- 
gestible tracer which accumulates in tissues following protein 
removal from the circulation and intracellular degradation in 
lysosomes. We believe that the technology which we have 
developed here provides an exciting new tool for investigating 
the sites, and eventually, the regulation of plasma protein 
catabolism in uiuo. 
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